Evaluation of sodium levels and changes in foods from the top 20 Canadian restaurant chains (2016–2020) against UK National Salt Reduction Maximum targets
PLOS One · 2025
DOI: 10.1371/journal.pone.0328525 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Caroline G Middleton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Restaurants, Sodium, Dietary, Sodium Chloride, Dietary. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institutes of Health Research.
Abstract (Originalsprache)
High sodium intake contributes to hypertension, a leading risk factor for cardiovascular disease. Over 50% of Canadians regularly consume prepackaged and restaurant foods, which account for more than 70% of dietary sodium. Canada currently lacks public health strategies to address sodium levels in restaurant menu items, while the UK’s voluntary sodium reduction program (with targets set through the National Salt Reduction Initiative [NSRI]) led to significant reductions in sodium. The objectives were to compare sodium levels in Canadian restaurant menu items in 2020 to the UK NSRI 2024 targets and analyze changes between 2016 and 2020. Data were obtained from the University of Toronto Menu-FLIP (Food Label Information and Price) database, which includes over 20,000 items from 141 Canadian chain restaurants. A total of 3,616 menu items from the top 20 Canadian chains were assessed, of which 1,914 items in categories with UK NSRI 2024 targets were identified and compared to those targets, and 607 items were matched between 2016 and 2020 and analyzed for sodium changes. More than half (56.6%, n = 1,083/1,914) of items exceeded UK NSRI targets. Sodium (mg/100 g) showed a large decrease in 39.5% ( n = 100/607) of items, a medium decrease in 15.8% ( n = 63/607), little change in 28.9% ( n = 182/607), a medium increase in 5.3% ( n = 68/607), and a large increase in 10.5% ( n = 194/607) from 2016 to 2020. The prevalence and magnitude of sodium changes varied by food category. Overall, there was a statistically significant but nutritionally insignificant reduction in sodium per serving from 2016 to 2020 (−24 ± 819 mg, p < 0.01). Canadian restaurant menu items were high in sodium, with more than half surpassing the UK NSRI targets. The observed increases and decreases in sodium highlight the need for Health Canada to set and for industry to adopt sodium reduction targets for restaurant menu items, similar to those in the UK.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Nutritional Sciences, Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
- Joannah & Brian Lawson Centre for Child Nutrition, University of Toronto, University of Toronto, Toronto, Ontario, Canada.
- School of Nutrition, Toronto Metropolitan University, Toronto, Ontario, Canada.
ORCID-Profile: Caroline G Middleton, Yahan Yang, Mary R L'Abbé
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
Middleton, C. G., Yang, Y., Ahmed, M., Lee, J. J., & L'Abbé, M. R. (2025). Evaluation of sodium levels and changes in foods from the top 20 Canadian restaurant chains (2016–2020) against UK National Salt Reduction Maximum targets. PLOS One. https://doi.org/10.1371/journal.pone.0328525
Vancouver
Middleton CG, Yang Y, Ahmed M, Lee JJ, L'Abbé MR. Evaluation of sodium levels and changes in foods from the top 20 Canadian restaurant chains (2016–2020) against UK National Salt Reduction Maximum targets. PLOS One. 2025. doi:10.1371/journal.pone.0328525
BibTeX
@article{Middleton2025,
author = {Middleton, Caroline G and Yang, Yahan and Ahmed, Mavra and Lee, Jennifer J and L'Abbé, Mary R},
title = {Evaluation of sodium levels and changes in foods from the top 20 Canadian restaurant chains (2016–2020) against UK National Salt Reduction Maximum targets},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0328525}
}
EUVIMED